ArticleCureus2025

The Potential Role of Serum Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) as a Biomarker of Fibrosis in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).

Aalia Tahseen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.